Are you evaluating quality systems and preparing for the 2026 QMSR requirements? Wondering what CMS' WISeR model means for reimbursement strategies? Planning preclinical studies or evaluating histopathology experts? Want to use phased testing to unlock funding, design for non-clinical environments, or better build supplier partnerships? We offer strategic guidance that makes your business "go faster" through our monthly insights.
INDUSTRY INSIGHTS FROM THE VERANEX BLOG
A Potential Reimbursement Bombshell: The WISeR Model
CMS's Prior Authorization Demonstration Could Dramatically Reshape Medicare Reimbursement Strategies for the Medical Device Industry.
Don't Confuse Software with a System: The eQMS Trap
Buying eQMS Software Doesn't Mean You're Buying a Quality Management System. That Misconception Could Cost Medical Device Innovators Regulatory Approval and Market Success.
Clinical success doesn't guarantee home success. How medical device innovators can design for the real constraints, users, and behaviors of a $75B market.
We are proud to sponsor this exclusive gathering of senior medtech leaders and innovators in Prague. Our team is excited to join the conversation on the future of medical technology, explore new ideas, and deepen partnerships that accelerate impactful solutions for patients worldwide.
Jose Pablo Morales, MD - Our New Chief Medical Officer
Advancing MedTech Innovation
Dr. Morales joins Veranex following a distinguished career at the U.S. Food and Drug Administration (FDA), where he provided clinical and regulatory oversight for more than 1,000 medical device submissions, including PMAs, IDEs, and breakthrough designations.
.png?upscale=true&width=1200&upscale=true&name=December%2025%20Insights%20from%20the%20Cutting%20Edge%20of%20Medtech%20(1).png)
